This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61388971%3A_____%2F07%3A00085743%21RIV08-AV0-61388971/
n8http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n6http://linked.opendata.cz/ontology/domain/vavai/
n10http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n15http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61388971%3A_____%2F07%3A00085743%21RIV08-AV0-61388971
rdf:type
n6:Vysledek skos:Concept
dcterms:description
Antibiotikum linkomycin a jeho deriváty působí hlavně proti Gram-pozitivním bakteriím a prvokům. Linkomycin a jeho chlorovaný derivát klindamycin, který je aktivnější než linkomycin, mají široké použití v medicině, často v kombinaci s jinými antibiotiky nebo neantibiotickými antimikrobiálními látkami Resistence k linkomycinu a klindamycin může být způsobena různými mechanismy. Článek popisuje chemickou strukturu linkosamidových antibiotik, analytické metody jejich identifikace, separace a isolace, biosyntézu linkomycinu a příbuzných látek a její genetickou kontrolu The antibiotic lincomycin and its derivatives are active against Gram-positive bacteria and protozoans. Lincomycin and its chlorinated derivative clindamycin, which is more active than lincomycin, are widely used in medicine, often in combination with other antibiotic or nonantibiotic antimicrobials. Resistance to lincomycin and clindamycin may be caused by several mechanisms. The review describes the chemical structure of lincosamide antibiotics, analytical procedures used for their identification, separation and isolation and the biosynthesis of lincomycin and related compounds and its genetic control The antibiotic lincomycin and its derivatives are active against Gram-positive bacteria and protozoans. Lincomycin and its chlorinated derivative clindamycin, which is more active than lincomycin, are widely used in medicine, often in combination with other antibiotic or nonantibiotic antimicrobials. Resistance to lincomycin and clindamycin may be caused by several mechanisms. The review describes the chemical structure of lincosamide antibiotics, analytical procedures used for their identification, separation and isolation and the biosynthesis of lincomycin and related compounds and its genetic control
dcterms:title
Medicinal Use of Lincosamides and Microbial Resistance to Them Medicinal Use of Lincosamides and Microbial Resistance to Them Lékařské aplikace linkosamidů a mikrobiální resistence k nim
skos:prefLabel
Lékařské aplikace linkosamidů a mikrobiální resistence k nim Medicinal Use of Lincosamides and Microbial Resistance to Them Medicinal Use of Lincosamides and Microbial Resistance to Them
skos:notation
RIV/61388971:_____/07:00085743!RIV08-AV0-61388971
n4:strany
133;144
n4:aktivita
n16:Z
n4:aktivity
Z(AV0Z50200510)
n4:cisloPeriodika
-
n4:dodaniDat
n15:2008
n4:domaciTvurceVysledku
n8:5924537 n8:8377898 n8:6536239
n4:druhVysledku
n13:J
n4:duvernostUdaju
n17:S
n4:entitaPredkladatele
n14:predkladatel
n4:idSjednocenehoVysledku
432675
n4:idVysledku
RIV/61388971:_____/07:00085743
n4:jazykVysledku
n9:eng
n4:klicovaSlova
lincomycin; clindamycin; lincosamide antibiotics
n4:klicoveSlovo
n11:clindamycin n11:lincosamide%20antibiotics n11:lincomycin
n4:kodStatuVydavatele
NL - Nizozemsko
n4:kontrolniKodProRIV
[55042863B7B4]
n4:nazevZdroje
Anti-Infective Agents in Medicinal Chemistry
n4:obor
n5:EE
n4:pocetDomacichTvurcuVysledku
3
n4:pocetTvurcuVysledku
3
n4:rokUplatneniVysledku
n15:2007
n4:svazekPeriodika
6
n4:tvurceVysledku
Řezanka, Tomáš Sigler, Karel Spížek, Jaroslav
n4:zamer
n10:AV0Z50200510
s:issn
1871-5214
s:numberOfPages
12